In an eye-opening report published by Mr.Mohit Sodhi on JAMA, the researchers have been able to discover that Ozempic has a whole new bunch of side effects.
In Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss, the scientists uncovered, “Use of GLP-1 agonists compared with bupropion-naltrexone was associated with increased risk of pancreatitis, bowel obstruction, and gastroparesis. As expected the users of the drug are concerned and the medical community has the answers for them.
Emerging New Side Effects From Ozempic Drug
Ozempic is a semaglutide or GLP-1 which is usually prescribed to type-2 diabetes patients to manage insulin levels. A type-2 diabetes patient has difficulty in the production of Insulin in their pancreas which usually controls the sugar in one’s blood. In cases like these, Ozempic injections are able to restore the glucose levels in the body bringing it back to the normal range. A once-in-a-week shot would be enough to control the excess glucose. But why has its popularity suddenly sky-rocketed?
The drug as prescribed by influencers and many celebrities is being endorsed as a popular weight loss drug. In fact, as per the stats reported by The New York Times, #ozempic has been “…viewed over 273 million times, with people alternately expressing shock over their supposed medication-induced weight loss and swapping stories about side effects.” Additionally, many doctors have confirmed that their non-diabetic patients have been demanding the medicine “off the record” to use it as a potential weight loss drug. So how does it help one lose weight?
According to doctors, the medicine responds similarly to the peptide-1 that is naturally produced in our body. Peptide triggers usually when we are satiated and don’t need to eat again. It triggers when to have food and when not, Moreover, the hunger pangs are also controlled by the hormone.
Related News:- Major Milestone: Research Points To A Halt In Alzheimer’s Disease Advancement.
When someone takes Ozempic, the body mimics the release of this hormone. That means one no longer feels hungry even though they might not have eaten as much as they need or as they always do. It is in direct tandem with the goals of intermittent fasting or dieting that decreases the amount of food one can eat. This ability of the medicine has attracted obese and fitness freaks to consume it as a means to manage their weight. However, the doctors warn that it is not designed to control weight.
But it doesn’t come up with its own sets of side effects that include vomiting, gastrointestinal problems, altered bowel movements, and experience weakness. When asked about its increasing intake, a doctor says, “It can be so bad that people go to the E.R. It’s no joke.
Patients should be monitored while taking these drugs.” Now the latest study reiterates the fact and observes, “This study found that use of GLP-1 agonists for weight loss compared with use of bupropion-naltrexone was associated with increased risk of pancreatitis, gastroparesis, and bowel obstruction but not biliary disease.
Related News:- California Nurses Association Against Governor Newsom’s Controversial Move By Signing S.B 700
Given the wide use of these drugs, these adverse events, although rare, must be considered by patients who are contemplating using the drugs for weight loss because the risk-benefit calculus for this group might differ from that of those who use them for diabetes.”
A doctor when asked a way to minimize the side effects said, “It’s important to work with people that know how to prescribe these and know how to titrate these medications accordingly. One of the things is that if you look at the package insert for these medications, it tells you to titrate these medications after one month of use.”
So in order to gain control over the side effects consistent change of doses could be key and that is what the experts suggest. However, it is still to be noted that F.D.A doesn’t approve it as a weight loss drug.
Related News:- Weight Loss Drugs Raise Red Flag For Serious Gastrointestinal Complications